![](/img/cover-not-exists.png)
18223 Long-term proactive management of psoriasis vulgaris with fixed-dose combination of 0.005% calcipotriene and 0.064% betamethasone dipropionate foam: Results of a phase III randomized controlled trial
Lebwohl, Mark, Lacour, Jean-Philippe, Liljedahl, Monika, Lynde, Charles, Holst Mørch, Marie, Marieke Snel-Prentø, Anja, Thaçi, Diamant, Warren, Richard B.Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.919
Date:
December, 2020
File:
PDF, 695 KB
2020